Phil-Robin Tepasse

InstitutionUniversity Hospital Münster
AddressMünster
Germany
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 11 Covid-19 publications, with a maximum of 2 publications in June 2021
    All Publications
    Bar chart showing 11 publications over 2 distinct years, with a maximum of 8 publications in 2021
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Kessel C, Vollenberg R, Masjosthusmann K, Hinze C, Wittkowski H, Debaugnies F, Nagant C, Corazza F, Vély F, Kaplanski G, Girard-Guyonvarc'h C, Gabay C, Schmidt H, Foell D, Tepasse PR. Discrimination of COVID-19 From Inflammation-Induced Cytokine Storm Syndromes Using Disease-Related Blood Biomarkers. Arthritis Rheumatol. 2021 10; 73(10):1791-1799. PMID: 33880885.
      Citations: 5     Fields:    Translation:Humans
    2. Jörrißen P, Schütz P, Weiand M, Vollenberg R, Schrempf IM, Ochs K, Frömmel C, Tepasse PR, Schmidt H, Zibert A. Antibody Response to SARS-CoV-2 Membrane Protein in Patients of the Acute and Convalescent Phase of COVID-19. Front Immunol. 2021; 12:679841. PMID: 34421894.
      Citations: 1     Fields:    Translation:Humans
    3. Tepasse PR, Vollenberg R, Fobker M, Kabar I, Schmidt H, Meier JA, Nowacki T, Hüsing-Kabar A. Vitamin A Plasma Levels in COVID-19 Patients: A Prospective Multicenter Study and Hypothesis. Nutrients. 2021 Jun 24; 13(7). PMID: 34202697.
      Citations: 4     Fields:    Translation:Humans
    4. Varghese J, Sandmann S, Ochs K, Schrempf IM, Frömmel C, Dugas M, Schmidt HH, Vollenberg R, Tepasse PR. Persistent symptoms and lab abnormalities in patients who recovered from COVID-19. Sci Rep. 2021 06 17; 11(1):12775. PMID: 34140539.
      Citations: 2     Fields:    Translation:Humans
    5. Wiegele PN, Kabar I, Kerschke L, Froemmel C, Hüsing-Kabar A, Schmidt H, Vorona E, Vollenberg R, Tepasse PR. Symptom Diary-Based Analysis of Disease Course among Patients with Mild Coronavirus Disease, Germany, 2020. Emerg Infect Dis. 2021 05; 27(5):1353-1361. PMID: 33900166.
      Citations: 1     Fields:    Translation:Humans
    6. Dugas M, Grote-Westrick T, Merle U, Fontenay M, Kremer AE, Hanses F, Vollenberg R, Lorentzen E, Tiwari-Heckler S, Duchemin J, Ellouze S, Vetter M, Fürst J, Schuster P, Brix T, Denkinger CM, Müller-Tidow C, Schmidt H, Tepasse PR, Kühn J. Lack of antibodies against seasonal coronavirus OC43 nucleocapsid protein identifies patients at risk of critical COVID-19. J Clin Virol. 2021 06; 139:104847. PMID: 33965698.
      Citations: 12     Fields:    Translation:Humans
    7. Vollenberg R, Matern P, Nowacki T, Fuhrmann V, Padberg JS, Ochs K, Schütte-Nütgen K, Strauß M, Schmidt H, Tepasse PR. Prone Position in Mechanically Ventilated COVID-19 Patients: A Multicenter Study. J Clin Med. 2021 Mar 03; 10(5). PMID: 33802479.
      Citations: 3     
    8. Dugas M, Grote-Westrick T, Vollenberg R, Lorentzen E, Brix T, Schmidt H, Tepasse PR, Kühn J. Less severe course of COVID-19 is associated with elevated levels of antibodies against seasonal human coronaviruses OC43 and HKU1 (HCoV OC43, HCoV HKU1). Int J Infect Dis. 2021 Apr; 105:304-306. PMID: 33636357.
      Citations: 16     Fields:    Translation:HumansCells
    9. Rovas A, Osiaevi I, Buscher K, Sackarnd J, Tepasse PR, Fobker M, Kühn J, Braune S, Göbel U, Thölking G, Gröschel A, Pavenstädt H, Vink H, Kümpers P. Microvascular dysfunction in COVID-19: the MYSTIC study. Angiogenesis. 2021 02; 24(1):145-157. PMID: 33058027.
      Citations: 42     Fields:    Translation:HumansCells
    10. Dugas M, Schrempf IM, Ochs K, Frömmel C, Greulich L, Neuhaus P, Tepasse PR, Schmidt HH. Association of contact to small children with a mild course of COVID-19. Int J Infect Dis. 2020 Nov; 100:314-315. PMID: 32898672.
      Citations: 3     Fields:    Translation:HumansPHPublic Health
    11. Tepasse PR, Hafezi W, Lutz M, Kühn J, Wilms C, Wiewrodt R, Sackarnd J, Keller M, Schmidt HH, Vollenberg R. Persisting SARS-CoV-2 viraemia after rituximab therapy: two cases with fatal outcome and a review of the literature. Br J Haematol. 2020 07; 190(2):185-188. PMID: 32557623.
      Citations: 39     Fields:    Translation:HumansCellsPHPublic Health
    Tepasse's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (77)
    Explore
    _
    Co-Authors (80)
    Explore
    _
    Similar People (60)
    Explore
    _